No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
211 |
4. Check minimum number of eventsNone |
211 |
5. Include endpointsNone |
211 |
6. Filter based on genotype QC (FinnGen only) |
184 |
Control definitions (FinnGen only)
- Control exclude
- AB1_OTHER_BACTERIAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Listeriosis, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Other bacterial diseases, including avohilmo
- Certain infectious and parasitic diseases, including avohilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 184 | 95 | 89 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.04 |
| Median age at first event (years) | 69.75 | 66.16 | 73.59 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 188
- Matched controls
- 1880
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A32.7
ICD-10 Finland
Listerial sepsis
+∞
158.6
129
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
61.0
101.8
59
14
R50.9
ICD-10 Finland
Fever, unspecified
7.1
34.3
67
136
A41.9
ICD-10 Finland
Sepsis, unspecified
+∞
31.1
29
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
11.7
27.2
30
30
G01*A32.1
ICD-10 Finland
Listerial meningitis
+∞
25.6
24
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.7
21.3
66
194
L04AX01
ATC
azathioprine; systemic
15.3
17.7
29
22
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
+∞
16.9
16
*
A46
ICD-10 Finland
Erysipelas
6.2
16.5
31
58
TK800
NOMESCO Finland
Hemodialysis
37.0
16.1
20
6
A41.8
ICD-10 Finland
Other specified sepsis
+∞
15.8
15
*
WX892
NOMESCO Finland
Monitored bed care
6.1
15.7
30
57
B03XA02
ATC
darbepoetin alfa; parenteral
22.4
15.5
22
11
N17.9
ICD-10 Finland
Acute renal failure, unspecified
12.9
14.3
25
22
ZX120
NOMESCO Finland
Intravenous
4.5
14.1
40
107
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
13.9
66
254
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
5.3
13.3
29
62
A32.8
ICD-10 Finland
Other forms of listeriosis
+∞
12.6
12
*
A32.1
ICD-10 Finland
Listerial meningitis and meningoencephalitis
+∞
12.6
12
*
B01AA03
ATC
warfarin; systemic
3.2
12.5
66
269
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.0
12.4
101
525
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
19.7
12.3
18
10
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
16.1
12.1
19
13
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.0
12.0
39
115
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
11.9
39
116
C03CA01
ATC
furosemide; systemic
2.9
11.8
98
511
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.6
11.3
23
46
H02AB06
ATC
prednisolone; systemic
2.9
11.1
114
658
L04AA06
ATC
mycophenolic acid; systemic
30.0
10.9
14
5
M05BA04
ATC
alendronic acid; oral
3.8
10.7
37
114
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
10.5
113
662
A32.9
ICD-10 Finland
Listeriosis, unspecified
+∞
10.5
10
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.9
10.5
35
105
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
14.2
10.4
17
13
ZXD05
NOMESCO Finland
Urgent procedure
2.8
10.1
74
356
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.7
10.0
25
60
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.4
9.7
26
66
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
9.6
58
250
A11CC03
ATC
alfacalcidol; systemic
11.6
9.5
17
16
J01MA12
ATC
levofloxacin; systemic
3.0
9.4
52
213
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
+∞
9.4
9
*
0270X
ICD-9 Finland
Other zoonotic bacterial diseases, Listeriosis[LISTERIOSIS ALIA (EI SYNNYNNÄINEN)]
+∞
9.4
9
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
9.3
74
368
Z49.1
ICD-10 Finland
Extracorporeal dialysis
38.7
9.1
11
*
J01MA02
ATC
ciprofloxacin; systemic
2.5
9.0
97
556
B01AB05
ATC
enoxaparin; parenteral
2.6
8.8
80
422
R2110
NOMESCO Finland
Giving the first information
4.9
8.6
20
45
N18.0
ICD-10 Finland
End-stage renal disease
94.1
8.5
9
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.8
8.5
52
225
N02AA05
ATC
oxycodone; systemic
2.7
8.5
56
252
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.6
8.4
21
50
I50.9
ICD-10 Finland
Heart failure, unspecified
2.8
8.3
50
214
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
4.6
8.2
20
47
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
9.1
8.0
16
19
WX002
NOMESCO Finland
Sedation and analgesia
2.7
8.0
54
245
JN4BD
NOMESCO Finland
Extensive body CT
3.4
7.9
31
103
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.6
7.9
28
87
UJF32
NOMESCO Finland
Coloscopy
2.5
7.9
66
332
127
Kela drug reimbursment
Transplant complication
26.2
7.7
10
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.1
7.6
35
128
XW000
NOMESCO Finland
Bone marrow biopsy
6.5
7.6
19
32
I50.0
ICD-10 Finland
Congestive heart failure
3.2
7.1
30
104
A03FA01
ATC
metoclopramide; systemic, rectal
2.5
7.0
54
259
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.5
7.0
26
83
SPAT1229
SPAT
Assessment of need for aid
3.5
7.0
25
78
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.0
7.0
21
58
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
41.6
6.8
8
*
L01BA01
ATC
methotrexate; systemic
6.9
6.8
16
25
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.9
6.8
36
143
N17.8
ICD-10 Finland
Other acute renal failure
23.5
6.7
9
*
A10AB05
ATC
insulin aspart; parenteral
3.5
6.6
24
76
L04AA01
ATC
[U] ciclosporin
15.0
6.5
10
7
L04AD02
ATC
tacrolimus; systemic
+∞
6.3
6
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
+∞
6.3
6
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.9
6.2
19
53
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
6.0
69
391
JN3AD
NOMESCO Finland
Abdominal CT examination
2.8
6.0
32
127
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
32
38
9.94
25.68
4.7
2.1
0.34
0.43
iu/ml
0.41
17
24
52
108
6.27
25.43
2.3
1.3
—
—
—
0
0
51
105
6.29
25.15
16.3
4.8
13.47
10.12
mmol/l
1.57
51
100
77
259
4.34
20.80
2.7
1.8
—
—
—
0
0
29
42
7.98
19.69
2.4
1.5
2.79
0.23
ug/l
1.87
29
31
33
75
5.12
14.20
3.6
2.8
1.99
2.03
mmol/l
0.02
25
57
126
717
3.30
13.55
13.6
3.9
32.06
35.76
g/l
7.64
120
673
57
204
3.57
13.36
2.3
1.7
—
—
—
0
0
25
50
5.61
12.33
3.9
2.4
—
—
—
0
0
25
52
5.39
11.81
1.8
1.1
—
—
—
0
0
21
37
6.26
11.76
2.2
1.2
—
—
—
0
0
28
66
4.81
11.47
3.7
1.6
6.96
11.41
iu/ml
0.35
11
16
137
870
3.12
11.22
25.5
8.7
4.75
4.03
e9/l
1.60
124
749
51
194
3.24
10.63
2.3
1.9
—
—
—
0
0
24
55
4.86
10.13
8.2
4.3
5.02
4.21
ratio
0.10
16
29
84
444
2.61
9.32
3.4
2.1
3.84
3.04
mg/l
1.59
75
370
21
32
7.25
8.96
2.0
1.3
—
—
—
0
0
14
10
15.00
8.84
1.4
1.2
—
—
—
0
0
18
38
5.13
8.30
2.1
1.4
—
—
—
0
0
25
70
3.97
8.17
1.7
1.3
—
—
—
0
0
15
16
10.08
7.94
2.2
1.8
—
—
—
0
0
14
14
10.70
7.67
2.3
1.9
—
—
—
0
0
125
874
2.28
6.60
22.6
5.9
1.19
1.22
mmol/l
5.14
112
752
39
164
2.74
6.59
9.3
2.8
-0.15
1.84
mmol/l
1.68
32
144
43
191
2.62
6.53
21.7
7.0
0.67
1.18
mmol/l
0.32
35
167
18
35
5.57
6.52
1.7
1.4
—
—
—
0
0
17
42
4.35
6.51
4.5
1.9
2.17
1.55
mg/l
1.42
17
34
116
790
2.22
6.49
19.4
5.2
1.19
1.22
mmol/l
4.90
109
720
94
591
2.18
6.41
4.4
3.2
4924.38
1176.13
ng/l
1.81
89
502
18
36
5.42
6.38
3.6
1.9
—
—
—
0
0
13
18
7.67
6.04
1.4
1.4
—
—
—
0
0
27
97
3.08
6.03
2.2
1.5
—
—
—
0
0
14
23
6.48
5.81
2.1
1.5
—
—
—
0
0
13
20
6.90
5.66
1.4
1.5
—
—
—
0
0
26
95
3.02
5.64
9.0
2.8
22.31
24.42
mmol/l
2.39
26
95
37
164
2.56
5.60
4.8
2.1
13.13
7.08
umol/l
0.89
32
145
79
487
2.07
5.46
5.2
3.1
0.26
0.37
e6/l
0.50
66
345
8
5
16.61
5.46
2.5
1.6
—
—
—
0
0
8
5
16.61
5.46
2.5
1.6
—
—
—
0
0
8
5
16.61
5.46
2.5
1.6
—
—
—
0
0
8
5
16.61
5.46
2.5
1.6
—
—
—
0
0
14
26
5.73
5.34
1.4
1.4
—
—
—
0
0
17
49
3.71
5.31
2.6
1.5
—
—
—
0
0
13
23
5.99
5.16
1.8
1.3
1202.00
1589.06
e6/l
—
6
18
14
28
5.31
5.05
1.4
1.4
—
—
—
0
0
12
20
6.33
5.00
3.9
2.2
13.29
16.10
%
1.72
12
20
45
235
2.20
4.69
15.1
6.0
104.64
103.96
mmol/l
0.40
45
235
9
11
8.52
4.61
2.3
1.9
—
—
—
0
0
9
11
8.52
4.61
2.3
1.9
—
—
—
0
0
9
11
8.52
4.61
2.3
1.9
—
—
—
0
0
7
5
14.46
4.61
1.1
1.2
—
—
—
0
0
7
5
14.46
4.61
1.4
1.2
—
—
—
0
0
7
5
14.46
4.61
1.0
1.4
—
—
—
0
0
7
5
14.46
4.61
1.1
1.2
—
—
—
0
0
17
55
3.30
4.49
4.1
1.6
—
—
—
0
0
103
732
1.90
4.47
6.3
2.6
—
—
estimate
—
0
0
52
296
2.05
4.31
4.7
2.9
0.81
1.13
e6/l
0.48
34
144
64
393
1.95
4.29
5.3
2.4
—
—
—
0
0
25
104
2.62
4.27
16.4
8.6
93.24
93.26
%
0.00
25
104
12
25
5.05
4.26
1.4
1.5
—
—
—
0
0
8
10
8.29
4.10
1.1
1.0
—
—
—
0
0
95
672
1.84
4.06
6.3
4.1
94.13
48.20
ng/l
0.49
79
521
48
276
1.99
3.84
4.9
3.1
3.22
2.43
e6/l
0.21
31
126
13
34
4.03
3.77
1.4
1.3
—
—
—
0
0
10
20
5.22
3.74
1.0
1.0
—
—
u/ml
—
0
0
7
9
8.02
3.59
1.1
1.3
—
—
—
0
0
13
36
3.80
3.57
1.2
1.3
—
—
—
0
0
8
13
6.37
3.54
5.8
2.2
—
—
—
0
0
9
18
5.19
3.41
1.3
1.3
—
—
—
0
0
99
735
1.73
3.39
3.6
2.4
86.17
78.14
nmol/l
1.74
94
642
6
7
8.80
3.28
1.3
2.0
—
—
—
0
0
11
29
3.96
3.24
3.3
2.4
7.48
7.93
kpa
0.42
11
29
11
29
3.96
3.24
1.3
1.4
—
—
—
0
0
11
29
3.96
3.24
1.3
1.4
—
—
—
0
0
8
16
5.17
3.08
1.1
1.3
17.25
12.94
u/l
—
8
16
50
314
1.81
3.01
2.4
1.7
1048.49
1147.05
nmol/l
0.36
41
230
5
5
10.22
2.99
4.2
1.0
—
—
—
0
0
5
5
10.22
2.99
1.2
1.2
—
—
—
0
0
5
5
10.22
2.99
1.2
1.0
—
—
—
0
0
5
5
10.22
2.99
1.2
1.2
—
—
—
0
0
7
13
5.55
2.89
6.0
1.4
-0.57
1.57
mmol/l
—
7
13
100
768
1.65
2.85
2.7
2.2
95.72
96.11
pmol/l
0.03
65
395
101
779
1.64
2.82
3.4
2.6
—
—
—
0
0
9
23
4.06
2.81
2.7
1.2
—
—
—
0
0
9
23
4.06
2.81
2.9
1.2
—
—
—
0
0
9
23
4.06
2.81
2.9
1.2
—
—
—
0
0
8
22
3.75
2.39
3.0
1.2
—
—
—
0
0
8
22
3.75
2.39
3.0
1.2
—
—
—
0
0
5
8
6.38
2.38
6.8
2.5
—
—
—
0
0
5
8
6.38
2.38
6.8
2.5
—
—
—
0
0
15
65
2.42
2.38
2.7
1.9
36.47
44.08
u/l
0.51
15
55
29
165
1.90
2.36
5.6
3.1
—
—
—
0
0
11
40
2.86
2.31
1.8
1.3
—
—
—
0
0
8
23
3.58
2.29
3.0
1.2
—
—
—
0
0
6
13
4.73
2.29
1.0
1.4
4.80
4.59
u/l
—
6
13
7
18
4.00
2.27
1.0
1.3
—
—
—
0
0
19
94
2.14
2.25
6.4
2.3
1.46
1.17
%
0.41
19
94
51
349
1.63
2.21
1.9
1.7
1.87
1.43
mg/l
0.48
46
278
112
918
1.54
2.20
6.8
2.9
81.01
43.73
u/l
1.88
106
848
9
31
3.00
2.10
3.9
2.1
113.78
129.14
g/l
—
9
22
5
10
5.10
2.08
2.4
3.7
0.80
1.00
%
—
5
10
105
857
1.51
2.05
7.6
4.3
0.00
8.83
estimate
0.50
27
184
7
21
3.42
1.98
2.3
11.3
10.01
6.69
mmol/l
—
7
15
5
11
4.64
1.95
1.0
1.1
—
—
—
0
0
6
16
3.84
1.95
2.8
1.3
3.53
3.12
u/ml
—
6
16
18
93
2.03
1.92
6.1
2.3
0.59
0.63
%
0.22
18
93
11
46
2.48
1.89
2.5
1.2
—
—
—
0
0
21
116
1.91
1.87
4.2
2.4
41.80
64.16
ml/min/173m2
—
10
37
102
844
1.46
1.76
7.8
4.3
0.00
0.00
estimate
-0.00
26
176
8
30
2.74
1.74
2.8
1.4
1368.63
356.84
mu/l
—
8
30
6
19
3.23
1.67
1.0
1.2
—
—
—
0
0
72
563
1.45
1.65
4.8
3.9
23.35
7.25
mg/mmol
1.42
53
348
63
486
1.45
1.53
9.4
4.3
0.00
0.00
estimate
-0.00
25
161
5
15
3.39
1.53
1.2
1.1
—
—
—
0
0
102
861
1.40
1.49
7.8
4.3
0.00
0.02
estimate
0.50
25
167
9
38
2.44
1.48
1.4
1.2
—
—
—
0
0
5
16
3.18
1.44
5.2
4.1
864.80
795.12
mg
—
5
16
5
16
3.18
1.44
1.2
1.1
—
—
—
0
0
5
16
3.18
1.44
1.2
1.1
—
—
—
0
0
51
658
0.69
1.43
2.4
1.9
1.43
1.25
mmol/l
1.13
45
544
5
17
2.99
1.36
1.2
1.1
—
—
—
0
0
128
1149
1.36
1.14
4.8
4.3
14.99
14.95
pmol/l
0.05
121
1023
136
1468
0.73
1.06
5.5
5.3
1.41
1.48
mmol/l
0.99
127
1334
9
48
1.92
1.02
1.6
1.2
—
—
—
0
0
13
77
1.74
0.98
41.4
4.5
1.78
1.55
%
0.26
13
72
6
28
2.18
0.92
11.2
2.6
17.67
16.96
u/ml
—
6
28
52
421
1.33
0.92
6.0
2.8
350.60
348.83
umol/l
0.03
45
363
138
1477
0.75
0.91
5.7
5.4
4.14
4.52
mmol/l
4.56
130
1353
8
48
1.70
0.80
1.6
1.2
—
—
—
0
0
5
25
2.03
0.73
2.8
2.0
1.15
1.21
mmol/l
—
5
25
5
25
2.03
0.73
2.8
2.0
104.60
106.40
mmol/l
—
5
25
9
142
0.62
0.73
2.1
1.4
—
—
—
0
0
36
441
0.77
0.67
5.5
4.9
19.23
22.55
%
0.58
23
235
143
1505
0.79
0.64
6.2
6.4
2.24
2.62
mmol/l
5.54
134
1373
6
35
1.74
0.58
1.2
1.4
—
—
—
0
0
32
261
1.27
0.54
1.2
1.3
7.11
9.19
u/ml
—
9
97
7
109
0.63
0.50
1.1
2.2
—
—
—
0
0
155
1490
1.23
0.46
58.8
14.7
27.73
23.09
mg/l
1.20
148
1218
133
1394
0.84
0.45
5.2
4.5
1.33
1.25
mmol/l
0.76
125
1257
5
34
1.48
0.40
6.0
2.2
15.58
7.52
pmol/l
—
5
34
10
71
1.43
0.40
1.5
1.4
—
—
—
0
0
27
318
0.82
0.37
3.0
3.5
0.73
0.84
ug/l
0.33
20
217
141
1463
0.86
0.37
5.7
5.7
6.24
6.03
mmol/l
0.79
131
1321
6
43
1.41
0.35
1.3
1.6
—
—
—
0
0
125
1193
1.14
0.34
59.6
20.2
15.00
13.77
%
9.07
125
1181
50
552
0.87
0.32
5.6
6.1
2.46
3.36
ug/l
0.50
45
483
7
98
0.70
0.31
1.1
2.0
—
—
—
0
0
43
387
1.14
0.28
8.4
4.7
1.02
1.02
kg/l
0.18
35
271
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
33
298
1.13
0.21
1.2
1.3
95.14
30.26
iu/ml
—
7
97
0
14
0.00
0.20
0.0
1.1
—
607.00
—
0
8
0
14
0.00
0.20
0.0
1.1
—
33.38
—
0
8
69
655
1.08
0.18
8.9
4.2
0.00
0.00
estimate
-0.00
23
147
156
1587
0.90
0.17
79.9
24.6
37.15
39.97
%
9.68
156
1566
156
1587
0.90
0.17
78.4
24.3
121.84
134.21
g/l
14.05
156
1566
156
1585
0.91
0.15
77.6
24.1
92.62
91.34
fl
1.90
156
1564
19
211
0.89
0.14
15.4
7.7
—
—
—
0
0
21
231
0.90
0.13
4.4
5.0
34.56
32.25
%
0.32
16
138
34
363
0.92
0.12
1.4
1.2
0.94
1.06
u/ml
—
10
92
142
1396
1.07
0.11
5.8
5.5
2.09
1.96
mu/l
0.56
133
1246
6
74
0.80
0.07
1.0
1.0
—
—
—
0
0
9
88
1.02
0.07
4.8
3.1
3.64
4.26
pmol/l
—
9
77
142
1436
0.95
0.06
8.2
7.0
40.81
39.64
mmol/mol
0.71
135
1323
19
200
0.94
0.04
1.8
1.5
—
—
—
0
0
156
1570
0.96
0.03
65.1
21.2
109.47
79.21
umol/l
4.22
156
1549
21
206
1.02
0.00
1.5
1.4
—
—
—
0
0
47
466
1.01
0.00
7.2
3.5
0.00
0.00
estimate
-0.00
21
141
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
51.56
—
0
9
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
88.71
—
0
7
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
51.40
—
0
6
0
7
0.00
-0.00
0.0
1.6
—
13.29
—
0
7
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_LISTERIOSIS_WIDE – Listeriosis, including avohilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).